COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic.
Kristin A. Waite, PhD
Advertisement
Articles by Kristin A. Waite, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Which Novel Drug Classes Hold Promise in Multiple Myeloma Therapy?
2
From Blunt Instruments to Molecular Precision: 40 Years of Oncology Evolution
3
FDA Type B Meeting Appears Successful for Givastomig in Gastric Cancers
4
Treating Biochemical Recurrence in Oligometastatic Prostate Cancer
5